However, the more recent work of Wang et al. (2023) suggests that this might not be the case (at least in cancer) given that total Myc inhibition would be the desired therapeutic goal in treating cancer and would more likely than not accelerate rather than slow aging as one of its potential side effects. The gene discussed is MYC; the disease is cancer.